Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 25;16(3):e0248585. doi: 10.1371/journal.pone.0248585

HIV testing behaviors and willingness to receive oral rapid HIV testing among dental patients in Xi’an, China

Bei Gao 1, Lirong Wang 2,*, Anthony J Santella 3, Guihua Zhuang 2, Ruizhe Huang 4, Boya Xu 5, Yujiao Liu 2, Shuya Xiao 2, Shifan Wang 2
Editor: Zixin Wang6
PMCID: PMC7993620  PMID: 33765025

Abstract

Introduction

HIV testing is an important strategy for controlling and ultimately ending the global pandemic. Oral rapid HIV testing (ORHT) is an evidence-based strategy and the evidence-based shows is favored over traditional blood tests in many key populations. The dental setting has been found to be a trusted, convenient, and yet untapped venue to conduct ORHT. This study assessed the HIV testing behaviors and willingness to receive ORHT among dental patients in Xi’an, China.

Methods

A cross-sectional survey of dental patients from Xi’an was conducted from August to September 2017. Dental patients were recruited using a stratified cluster sampling. A 44-item survey was used to measure HIV/AIDS knowledge, HIV testing behaviors, and willingness to receive ORHT.

Results

Nine hundred and nine dental patients completed the survey with a mean HIV/AIDS knowledge score of 10.7/15 (SD 2.8). Eighty-four participants (9.2%) had previously received an HIV test. Participants would have a high rate of HIV testing if they had higher monthly income (OR = 1.982, 95% CI: 1.251–3.140) and a higher HIV/AIDS knowledge score (OR = 1.137, 95% CI: 1.032–1.252). Five hundred and eighty-two participants (64.0%) were willing to receive ORHT before a dental treatment, 198 (21.8%) were not sure, and 129 (14.2%) were unwilling. Logistic regression showed that age (OR = 0.970, 95% CI: 0.959–0.982), HIV/AIDS knowledge score (OR = 1.087, 95% CI: 1.031–1.145), previous HIV test (OR = 2.057, 95% CI: 1.136–3.723), having advanced HIV testing knowledge (OR = 1.570, 95% CI: 1.158–2.128), and having advanced ORHT knowledge (OR = 2.074, 95%: CI 1.469–2.928) were the factors affecting the willingness to receive ORHT.

Conclusions

The majority of dental patients had not previously received an HIV test, although many were receptive to being tested in the dental setting. The dental setting as a venue to screen people for HIV needs further exploration, particularly because many people do not associate dentistry with chairside screenings. Increasing awareness of ORHT and reducing testing price can further improve the patient’s willingness to receive ORHT.

Introduction

Although the life expectancy of people living with HIV (PLWH) has improved in the past decades [1], HIV/AIDS remains an issue of public health significance. By the end of 2019, 32.7 million people have died from AIDS-related illnesses since the start of the epidemic and 38.0 million people globally were living with HIV [2].

HIV testing is a vital strategy for controlling the pandemic. Early detection of HIV infection is an effective way to decrease HIV transmission. People aware of their infection have the opportunity to reduce their risk behaviors and receive antiretroviral treatment (ART) to achieve viral suppression [3]. It is reported that the transmission rate among persons unaware was three to seven times than those aware of their infections [4].

Unfortunately, HIV infections are often undiagnosed and diagnosed late including concurrently with AIDS [5]. In 2019, only 81% of PLWH knew their status worldwide [2]. In China, cumulative 850,000 PLWH were reported by the end of 2018, based on the estimates of 1,250,000, almost one-third of the PLWH have not yet been tested and diagnosed [6]. Zhang [7] estimated that the average time from infection and being tested was 6.8 ± 2.7 years in China. In Xi’an, a populous urban city in Northwest China, the late diagnosis rate of the newly identified HIV/AIDS was 31.1% (436/1,402) in 2017 [8].

Lacking testing venues is an important reason for low and delayed diagnoses. To expand testing venues, opt-out HIV testing has been implemented in medical settings since 2008 among priority populations and settings such as perinatal exams, prenatal exams, pre-operative exams, sexually transmitted disease exams and other types of testing services in China [9]. Almost half (44.7%) of 528,234 persons diagnosed with HIV between 2006 and 2014 in China were diagnosed at hospitals, indicating that most of the HIV testing in China was conducted in health and hospital systems [10]. However, dental patients are nor high-risk groups or sentinel surveillance groups. For both opt-out and opt-in testing, it is necessary to first understand the population’s HIV testing willingness. Otherwise, even if opt-out is carried out, a considerable number of people may refuse to be tested. The Chinese government has also explored the feasibility of offering HIV testing in at primary healthcare settings such as community health centers [11]. However, since China is a low-prevalence country, such a practice is still being explored. More research is needed to evaluate the effectiveness of this setting and other non-traditional settings such as dentistry.

Oral manifestations are among the earliest and most important clinical indicators in HIV infection and are important facilitators for recognizing, monitoring, and predicting the course of the disease [12, 13]. Few people with HIV infection fail to experience oral lesions during the course of their disease [14]. According to previous studies, rampant carries, severe periodontitis and oral candidiasis are the most notable oral lesions in PLWH [13, 15, 16].

The first oral rapid HIV test (ORHT) was approved by the United States (U.S.) Food and Drug Administration (FDA) in 2004 [17]. In the U.S. and other high-income countries, scholars have proposed that ORHT has the potential to improve the diagnosis rate of PLWH [18, 19]. The tests have high sensitivity and specificity; both above 99% [2022]. It also offers many advantages over blood-based testing and could address several challenges in implementing HIV testing in settings without laboratories [20]. This testing method does not require blood collection, has no risk of occupational exposure and cross-infection, and can prevent the patient from refusing to test because of fear of blood draw [23].

Studies about HIV testing in dental settings showed that most dentists have positive attitudes to ORHT and are willing to administer the test [2427]. A cross-sectional survey of dentists from Xi’an revealed that 91.2% of 477 respondents thought that ORHT was needed in private dental practice [24], 88.6% of 475 dentists belonging to the Korean Dental Association thought ORHT was necessary in dental settings [25], and a study from four cities in India reported that the proportion was 79.9% (402/503) [26], 65.1% of 532 responders from a survey conducted in Australia believed that ORHT was needed in private dental practice [27]. Dentists have the skill set to deliver difficult news and to ensure appropriate treatment or referral [28, 29]. According to a representative survey of dentists from the U.S., 56.7% (1022/1802) were willing to offer HIV testing [30], and in another survey conducted in Vietnam, the proportion was 90% (38/42) [31].

One of the concerns about rapid HIV screening is the dental patients’ acceptance [32]. Research about rapid HIV testing acceptance has been conducted in high HIV prevalence jurisdictions. A majority, 72.2% (293/406), of dental patients in New York City (U.S.) were agreed to have HIV testing performed in dental hygiene clinics [33]. Additionally, 84.5% of the 600 patients surveyed in South Florida (U.S.) accepted the ORHT offered by a dentist [34]. These studies focused on cities with high HIV prevalence; whether these attitudes would hold true in moderate and low prevalent cities and suburban and rural areas, remains unknown.

Given the lack of studies about dental patients’ acceptance towards ORHT in China, we conducted a cross-sectional survey Xi’an, located in Northwest China. The number of HIV/AIDS cases in Xi’an has increased from year to year from 2005 to 2017 [35]. The aim of the present study was to explore HIV testing behaviors and willingness to receive an ORHT among dental patients in Xi’an.

Methods

Study design and participants

A cross-sectional survey was conducted among dental patients in Xi’an from August to September 2017. First, practices from a sampling frame of dental practices in Xi’an were divided into three groups according to their setting type (dental hospital, department of dentistry in a general hospital and private dental practice). Then, practices were selected randomly amongst all three types. Dental patients 18 years and older who visited the sample practices from August to September were invited to participate in the survey. The proportion of participants who were willing to receive ORHT ranged from 24% to 91% [36]. If we take 24% as the expected proportion of our survey, α = 0.01 and the allowable error d = 0.15P, according to the formula n=tα2PQd2, which is commonly used to estimate the sample size of cross sectional study, then the approximately sample size would be 934.

The study team presented a short introduction about ORHT to all the participants (enough so they would be aware of what the survey was about but not too much that it would influence their results) and after obtaining their consent surveyed their knowledge and attitudes toward HIV/AIDS and ORHT. The investigators were trained graduate students. One member of the team was responsible for implementing the survey, the other was responsible for explaining the purpose of the survey, consenting the participant, and checking the survey after it was completed to ensure it was complete.

All study procedures and consent processes were approved by the ethics committee (Institutional Review Board) of Xi’an Jiaotong University. The written informed consent was obtained from each participant.

Data collection

The survey instrument was modified from a validated questionnaire from researchers in the U.S. [33]. An expert consensus panel of Chinese dental, sexual health, and epidemiology scholars reviewed a draft questionnaire to conform the validity. The questionnaire was pre-tested among 20 patients in Xi’an, and we modified the questionnaire based on the results, including the order of the questions, some inappropriate options and inaccurate expression of the questions. The final questionnaire consisted of 44 questions, assessing socio-demographic characteristics (eight items), HIV/AIDS knowledge (modified HIV-KQ-18 [37] (fifteen items), HIV testing behaviors (seven items), HIV testing knowledge (six items), ORHT knowledge (three items) and the willingness to receive ORHT (five items). We assessed ORHT knowledge by asking participants what the advantages of ORHT were, the options were high accuracy, quick results, and no need to draw blood. To collect the willingness to receive ORHT, we asked the participants: “If a dentist can carry out Oral Rapid HIV Testing, would you be willing to test it before treating oral diseases?”. The answers were yes, unwilling and unsure. For participants who chose “yes”, we categorized them as willing to use ORHT.

Analysis

Statistical Package for the Social Sciences (SPSS), version 13.0 was used for statistical analyses. Questions about HIV knowledge contained 15 items and each correct item was awarded one mark and the maximum score was 15. Knowledge of HIV testing and ORHT contained six items and three items, respectively. Responders who answered one or more questions correctly were identified as having advanced HIV testing or ORHT knowledge.

Differences between groups were tested using t-test or one-way ANOVA for continuous variables and chi-squared statistic for categorical variables. Unconditional logistic regression was used to analyze factors influencing HIV testing behaviors and willingness to receive an ORHT. Statistical significance was assessed using a two-sided test at the α = 0.05 level for all studies.

Results

Participant characteristics

Of the 909 participants, the mean age was 34.4 years (SD 12.3), 398 (43.8%) were male, 482 (53.1%) had completed college and/or graduate school, 551 (60.6%) were married, 286 (32.1%) had a monthly income more than 5000 yuan RMB (708.4 USD); 506 (55.7%) were from dental hospitals, 307 (33.8%) were from department of dentistry in general hospitals, 96 (10.6%) were from private dental practice. The average HIV knowledge score was 10.7 (out of 15) (SD = 2.8). The three questions with the lowest correct answer rate were: mosquito biting can’t transmit HIV/AIDS (24.4%), coughing and sneezing can’t transmit HIV/AIDS (55.7%), and there is no effective vaccine for HIV/AIDS (58.0%). Other participant characteristics are presented in Table 1.

Table 1. Participants’ characteristics and HIV testing behavior.

Total (N = 909) Received an HIV Test previously t2 P
Yes (n = 84) No (n = 825)
Age, X- (SD) 34.4(12.3) 36.1(11.4) 34.2(12.4) -1.366 0.172
Sex, n (%)
 Male 398(43.8) 34 (8.5) 364 (91.5) 0.412 0.521
 Female 511(56.2) 50 (9.8) 461 (90.2)
Nationality n (%)
 Han 889(97.8) 80 (9.0) 809 (91.1) 2.823 0.093
 Others 20(2.2) 4(20.0) 16 (80.0)
Education*, n (%)
 High school and lower 425(46.9) 28 (6.6) 397 (93.4) 6.800 0.009
 College and above 482(53.1) 56 (11.6) 426 (88.4)
Marriage*, n (%)
 Unmarried 357(39.3) 23(6.4) 334 (93.6) 5.489 0.019
 Married 551(60.6) 61 (11.1) 491 (88.9)
Monthly income*, n (%)
 ≥ 5000 yuan RMB (708.4 USD) 286(32.1) 40 (14.0) 246 (86.0) 10.931 0.001
 <5000 yuan RMB (708.4 USD) 606(67.9) 43 (7.1) 563 (92.9)
Employment Status, n (%)
 Employed 559(61.5) 53 (9.5) 506 (90.5) 0.100 0.752
 Unemployed 345(38.0) 31(8.9) 319 (91.1)
Type of dental setting visited, n (%)
 Dental hospital 506(55.7) 43(8.5) 463(91.5) 1.999 0.368
 Department of dentistry 307(33.8) 34(11.1) 273(88.9)
 Private dental practice 96(10.6) 7(7.3) 89(92.7)
HIV Knowledge Score, X- (SD) 10.7(2.8) 11.6(2.5) 10.6(2.8) 2.928 0.003

* Not all the participants answered the question.

HIV testing behaviors

Eighty-four participants (9.2%) had previously been tested for HIV, among which 73 (86.9%) were tested in hospitals, 4(4.8%) were in Center for Disease Control and Prevention (CDC) and 5 (6.0%) were tested when donating blood. Among the 39 participants who remembered the price of the test, 16 (41.0%) paid more than 100 yuan RMB (14.3 US dollars), 2 (5.1%) paid 51 to 100 yuan RMB (7.3–14.3 US dollars), 5(12.8%) paid 1 to 50 yuan RMB (0.1–7.2 US dollars), 16 (41.0%) were tested for free.

HIV testing behaviors by different demographic characteristics are shown in Table 1. The HIV testing rate among participants who had completed college and/or graduate school was 11.6%, which is higher than that among participants who had their highest level of education as high school (11.6% vs. 6.6%; χ2 = 6.800, p<0.05). The married participants’ HIV testing rate was higher than unmarried (11.1% vs. 6.4%; χ2 = 5.489, p<0.05). The participants whose monthly income was higher than 5000 yuan RMB (708.4 USD) had a higher HIV testing rate than those who had a lower monthly income (14.0% vs. 7.1%; χ2 = 10.931, p<0.05).

In multiple logistic regression analyses, participants would have a higher rate of HIV testing if they had higher monthly income (OR = 1.982, 95% CI: 1.251–3.140) or higher HIV knowledge score (OR = 1.137, 95% CI: 1.032–1.252) (Table 2).

Table 2. Predictors of conducting HIV testing.

B S.E Wals df Sig. OR 95% C.I.
Lower Upper
Monthly Income 0.684 0.235 8.480 1 0.004 1.982 1.251 3.140
HIV Knowledge Score 0.128 0.049 6.750 1 0.009 1.137 1.032 1.252
Constant -4.652 0.644 52.238 1 <0.001 0.010

Willingness to receive an ORHT

After a short introduction about ORHT, participants who had high/advanced HIV testing or ORHT knowledge were 452 (49.7%) and 720 (79.2%), respectively. In details, for the advantages of ORHT, the rate of choosing “quick results”, “no need to draw blood” and “high accuracy” are 561(61.7%), 450(49.5%), and 360(39.6%), respectively. And other questions are presented in Table 3. Of the 909 participants, 582 (64.0%) were willing to receive ORHT before a dental treatment, 198(21.78%) were not sure, and 129 (14.2%) were unwilling to receive an ORHT. When asked about the highest price they would pay for an ORHT, 132 (22.8%) chose free, 43 (7.4%) chose 10 yuan RMB (1.4 USD), 119 (20.5%) chose 30 yuan RMB (4.3 USD), 180 (31.0%) chose 50 yuan RMB (7.2 USD), 106(18.3%) chose 80 yuan RMB (11.3 USD), respectively.

Table 3. Details about HIV testing knowledge (n = 909).

Questions n (answer question correctly) %
AIDS can be tested by venous blood 354 38.90
AIDS can be tested by fingertip blood 200 22.00
AIDS can be tested by oral mucosa exudate 177 19.50
ORHT can get results quickly 561 61.72
ORHT doesn’t need draw blood 450 49.50
ORHT has high accuracy 360 39.60

Willingness to receive an ORHT by different demographic characteristics are shown in Table 4. Participants who were willing to receive ORHT were younger than the participants who were not willing (32.9 vs. 40.5; F = 20.802, p<0.05). Additionally, 66.9% of female participants were willing to receive an ORHT, which was higher than for males (66.9% vs. 60.3%; χ2 = 7.060, p<0.05). The mean HIV knowledge score of participants who were willing to receive an ORHT was 11.1 (2.5) out of 15, which was higher than that among participants who were not willing (11.1 vs. 10.2; F = 93.006, p<0.05). For participants who previously received an HIV test, the proportion willing to receive an ORHT, not willing and not sure was 68 (81.0%), 6 (7.1%) and 10 (11.9%) respectively, which is different from those who had not previously received an HIV test (χ2 = 11.527, p = 0.003). For participants who identified as having advanced HIV testing knowledge, the proportion for being willing to receive ORHT, not willing and not sure was 323 (71.5%), 51 (11.3%) and 78 (17.3%) respectively, which is different from those who had low HIV testing knowledge (χ2 = 21.571, P<0.001). For participants who had advanced ORHT, the proportion for being willing to receive ORHT, not willing and not sure was 492 (68.3%), 93 (12.9%), 135 (18.8%), which is different from those who had a low knowledge of ORHT (χ2 = 28.614, P<0.001).

Table 4. Participants’ willingness to receive an oral rapid HIV test.

Willingness to receive ORHT F/χ2 P
Yes (n1 = 582) No (n2 = 129) Unsure (n3 = 198)
Age, M (SD) 32.9(11.7) 40.5(14.3) 34.8(11.7) 20.802 <0.001
Sex, n (%)
 Female 342(66.9) 74(14.5) 95(18.6) 7.060 0.029
 Male 240(60.3) 55(13.8) 103(25.9)
Nationality, n (%)
 Han 572(64.3) 126(14.2) 191(21.5) 2.278 0.320
 Others 10(50.0) 3(15.0) 7(35.0)
Education*, n (%)
 High school and lower 247(58.1) 72(16.9) 106(24.9) 12.381 0.002
 College and above 334(69.3) 57(11.8) 91(18.9)
Marriage*, n (%)
 Unmarried 258(72.3) 32(9.0) 67(18.8) 19.618 <0.001
 Married 324(58.8) 96(17.4) 131(23.8)
Monthly income*, n (%)
 ≥ 5000 yuan RMB (708.4 USD) 189(66.1) 37(12.9) 60(21.0) 0.897 0.639
 <5000 yuan RMB (708.4 USD) 382(63.0) 90(14.9) 134(22.1)
Employment Status, n (%)
 Employed 372(66.5) 77(13.8) 110(19.7) 4.570 0.102
 Unemployed 210(60.0) 52(14.9) 88(25.1)
Type of dental setting visited, n (%)
 Dental hospital 330(65.2) 68(13.4) 108(21.3) 1.052 0.902
 Department of dentistry 193(62.9) 45(14.7) 69(22.5)
 Private dental practice 59(61.5) 16(16.7) 21(21.9)
HIV Knowledge Score, M (SD) 11.1(2.5) 10.2(3.4) 10.1(3.1) 12.024 <0.001
Previously received an HIV test, n (%)
 Yes 68(81.0) 6 (7.1) 10(11.9) 11.527 0.003
 No 514(62.3) 123(14.9) 188(22.8)
Having advanced HIV testing knowledge
 Yes 323(71.5) 51(11.3) 78(17.3) 21.571 <0.001
 No 259(56.7) 78(17.1) 120(26.3)
Having advanced ORHT knowledge
 Yes 492(68.3) 93(12.9) 135(18.8) 28.614 <0.001
 No 90(47.6) 36(19.0) 63(33.3)

*Not all the participants answered the question.

All variables in Table 5 were entered in running the multiple logistic regression analysis using the forward: conditional method. Five independent variables predicted willingness to receive an ORHT (Table 6). These were: younger (OR = 0.970, 95% CI: 0.959–0.982), higher HIV knowledge score (OR = 1.087, 95% CI: 1.031–1.145), previously received an HIV test (OR = 2.057, 95% CI: 1.136–3.723), having advanced HIV testing knowledge knowing (OR = 1.570, 95% CI: 1.158–2.128), and having advanced ORHT knowledge (OR = 2.074, 95%: CI 1.469–2.928).

Table 5. Variables in multiple logistic regression analysis.

Variables value
Willingness to undergo ORHT Y 0 = no or unsure;1 = yes
Age X1 Actual age of participants
Sex X2 1 = male; 2 = female
Nationality X3 1 = han; 2 = others
Education X4 1 = high school and low; 2 = college and above
Marriage X5 1 = unmarried; 2 = married
Monthly income X6 1:≤5000; 2:>5000
Employment status X7 0 = unemployed; 1 = employed
Type of dental setting visited X9 1 = dental hospital; 2 = department of dentistry; 3 = private dental practice
HIV Knowledge Score X10 Actual score of HIV knowledge (range from 0 to 15)
Previously received an HIV test X11 0 = no; 1 = yes
Having advanced HIV testing knowledge X12 0 = no; 1 = yes
Having advanced ORHT knowledge X13 0 = no; 1 = yes

Table 6. Predictors of willingness to receive an ORHT.

B S.E Wals df Sig. OR 95% C.I.
Lower Upper
Age -0.030 0.006 25.419 1 <0.001 0.970 0.959 0.982
HIV Knowledge Score 0.083 0.027 9.537 1 0.002 1.087 1.031 1.145
Previously received an HIV test 0.721 0.303 5.677 1 0.017 2.057 1.136 3.723
Having advanced HIV testing knowledge 0.451 0.155 8.418 1 0.004 1.570 1.158 2.128
Having advanced ORHT knowledge 0.730 0.176 17.205 1 <0.001 2.074 1.469 2.928
Constant -0.085 0.367 0.053 1 0.817 0.919

For the 327 participants who didn’t want ORHT, we further investigated the reasons. 185 (56.6%) thought they were healthy enough and detecting HIV was unnecessary, 93 (28.4%) thought that there was no relationship between HIV/AIDS and their oral diseases, 56 (17.1%) thought it was a waste of time. Other reasons are shown in Table 7.

Table 7. Major reasons participated cited for not wanting a ORHT (n = 327).

Reasons n %
Healthy enough 185 56.6
Not related to their dental diseases 93 28.4
Waste of time 56 17.1
Worried about the inaccuracy of the test 52 15.9
Not able to bear the result (if reactive) 26 8.0
Worry about the discrimination 26 8.0
Others 20 6.1

Discussion

HIV testing has been a powerful measure to realize the UNAIDS 90-90-90 goal, which means 90% of all PLWH knowing their status, 90% of these individuals receiving sustained ART and 90% of those on ART having virologic suppression [38]. But in China, the diagnose rate is still far from 90% [6].

PLWH are susceptible to oral diseases, causing dental patients to become a risk group [39]. The HIV testing rate of dental patients in China was not optimistic. Li conducted a case-control study at a private dental practice in Yuxi People’s Hospital in Yunnan Provence in China, 23.9% of 577 participants who refused to accept HIV screening cited they received HIV testing previously [40]. The current survey showed that 9.2% of 909 participants received HIV testing previously, and 86.9% (73/84) were tested in hospitals. HIV testing requires strong enforcement to reach the 90-90-90 goals, and besides hospitals, the dental setting can be used to screen persons for HIV.

A cross-sectional study in South Florida (U.S.) found that HIV knowledge was significantly related to previous HIV testing [41]. We found that dental patients who had higher monthly income, higher HIV/AIDS knowledge score had a higher HIV testing rate. Therefore, health education among dental patients can improve their awareness of HIV/AIDS and further increase their testing rate.

As ORHT is easy to administer and results can be read within 20 minutes, several researchers had explored the ORHT acceptance [12, 42, 43]. A study conducted in a hospital emergency department in Boston (U.S.) revealed that 68.8% of 821 responders are willing to accept ORHT, similar to that of finger-stick testing [43]. For most-at-risk people, two cross-sectional studies conducted in Beijing (China) and Shandong (China) suggested that the ORHT acceptance rate was 85.1% (223/262) and 70.9% (806/1137), respectively [12, 42]. Our study found that 64.0% of 909 participants were willing to receive an ORHT.

In the current study, we observed that those with high HIV knowledge scores, having advanced HIV testing and ORHT knowledge, experience of HIV testing had more willingness than those who hesitated or rejected to receive ORHT. Improving HIV-related knowledge is an essential and inexpensive way that can influence the acceptance rate. In addition to HIV knowledge, HIV testing knowledge and ORHT knowledge cannot be ignored, it should also be an important content of health education. Participants may change their mind if they recognize ORHT as a rapid, accurate and moderately priced HIV screening method. According to select U.S. studies, 84.6% (225/266) participants reported they would likely accept the HIV test if they received a physician’s recommendation [44]. Studies have shown that dentist were willing to carry out ORHT among their patients [29]. If recommended by a dentist, dental patients’ willingness to receive ORHT will likely improve.

Barriers for ORHT acceptance among dental patients included being tested for HIV previously, feeling confident about their health status, lack of time to wait for the test result, not wanting to be tested in a private dental practice and expensive testing cost [34, 40]. In our study, 56.6% of 327 participants believed they were sufficiently healthy indicating they were not interested in receiving an ORHT. This is inconsistent with the body of literature that has established the role of discrimination in persons rejecting HIV test offers [45]. One reason for not citing discrimination has a barrier to receiving an ORHT may be because the participants were established patients of the clinic where they were surveyed and satisfied with the quality of dental services they were receiving from their providers. Over a quarter (28.4%) of 327 participants thought that ORHT is not related with their oral diseases, from which we can speculated that some participants were not familiar with the oral manifestations of HIV. In fact, private dental practice are not risk-free places for HIV. Several participants expressed concern about the ORHT inaccuracy and not being a good use of their time. Therefore, carrying out health education on HIV and ORHT is necessary to improve the sense of risk of HIV and knowledge degree of ORHT to improve the acceptance.

For most-at-risk populations (including men who have sex with men (MSM), female sex workers and voluntary counseling and testing clients) in Shandong, a province in eastern China, the median price they would pay for ORHT ranged from 34 to 57 yuan RMB (4.8 to 8.2 USD) [42]. Moreover, the median price for MSM in Beijing (China) who were willing to pay was 57 yuan RMB (8.1 USD) [12]. In current study, 46.1% (18/39) participants who tested for HIV previously paid for more than 51 yuan RMB (7.3 USD). And for the 582 participants who were willing to receive an ORHT, the median price they were willing to pay was 30 yuan RMB (4.3 USD), lower than the mentioned studies among most-at-risk people. More specifically, 69.8% of the 580 participants accepting ORHT in the dental setting would accept HIV testing at a cost of 30 yuan RMB (4.3 USD), and 49.3% would be willing to pay 50 yuan RMB (7.2 USD) for ORHT. Undoubtedly, more acceptance would be gained if the price become lower.

Additional studies are needed to implement ORHT in dental practices and assess HIV prevalence rate among dental patients, and evaluating the prospect of promoting ORHT in the dental setting. In the future, our study team plans to select dental venues in high prevalent neighborhoods to assess the feasibility of implementing ORHT among dental patients.

Study limitations include (1) most of the dental patient participants were from local jurisdictions and their results may not be generalizable to the larger population, (2) we recruited less participants from private dental practices because some private dental practice refused to participate because of fear of affecting the patient’s medical experience, which may lead to some section bias, and (3) lack of information on survey non-responders.

Conclusion

The majority of dental patients had not previously received an HIV test, although many were receptive to being tested in the dental setting. The dental setting as a venue to screen people for HIV needs further exploration, particularly because many people do not associate dentistry with HIV and other chairside screenings for chronic diseases. Increasing awareness of ORHT and reducing testing price can further improve the patient’s willingness to receive ORHT.

Supporting information

S1 Data

(SAV)

S1 Questionnaire

(DOCX)

S2 Questionnaire

(DOCX)

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

We would like to thank the National T&S Major Project of China (grant no. 2018ZX10721202) for supporting us. The sponsors were not involved in the study design; collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.

References

  • 1.Deeks S, Lewin S, Havlir D. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33. 10.1016/S0140-6736(13)61809-7 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.UNAIDS, Global HIV & AIDS statistics—2020 fact sheet, 2020, https://www.unaids.org/en/resources/fact-sheet,(accessed Jan, 23, 2021).
  • 3.Dailey AF H B, Hall HI, Song R, Hayes D, Fulton P, Prejean J, et al. Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays—United States. Morbidity and Mortality Weekly Report 2017;66(47):1300–6. 10.15585/mmwr.mm6647e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hall HI H D, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):887–96. [DOI] [PubMed] [Google Scholar]
  • 5.Wilton J, Light L, Gardner S, Rachlis B, Conway T, Cooper C, et al. Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999–2013). HIV medicine. 2019;20(2):110–20. 10.1111/hiv.12686 . [DOI] [PubMed] [Google Scholar]
  • 6.Progress of AIDS prevention and control in China, 2018. http://www.chinaaids.cn/xxgx/yqxx/201811/t20181123_197488.htm, (accessed Jan, 23, 2021). [Internet]. http://www.chinaaids.cn/xxgx/yqxx/201811/t20181123_197488.htm.
  • 7.Zhang C, Ren Q, Chang W. Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China. International journal of environmental research public health. 2020;17(6). 10.3390/ijerph17061990 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hailan Z, XiaoLi W, Xin Z, Haichao Z. Influencing factors of late diagnosis of newly identified HIV/AIDS cases in Xi’an, 2011–2017 China Tropical Medicine. 2018;18(08):799–803+ 40. [Google Scholar]
  • 9.Xia Jin, Ran Xiong, Yurong M. HIV/AIDS cases detection in medical institutions from 2008 to 2013 in China. Chinese Journal of Epidemiology. 2015;36(4):323–6. [PubMed] [Google Scholar]
  • 10.Tang H, Mao Y, Tang W, Han J, Xu J, Li J. Late for testing, early for antiretroviral therapy, less likely to die: results from a large HIV cohort study in China, 2006–2014. BMC infectious diseases. 2018;18(1):272. 10.1186/s12879-018-3158-x . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ong JJ, Peng MH, Wong WW, Lo Y-R, Kidd MR, Roland M, et al. Opportunities and barriers for providing HIV testing through community health centers in mainland China: a nationwide cross-sectional survey. BMC Infectious Diseases. 2019;19(1):1054. 10.1186/s12879-019-4673-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Xu Y, Zhang Z, Li D, Liu Y, Pan SW, Qi X, et al. Willingness to use the oral fluid HIV rapid test among men who have sex with men in Beijing, China. PLoS One. 2013;8(5):e64652. 10.1371/journal.pone.0064652 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ranganathan K, Umadevi K. Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols. Periodontology. 2019;80(1):177–88. 10.1111/prd.12274 . [DOI] [PubMed] [Google Scholar]
  • 14.Greenspan D, Greenspan J. HIV-related oral disease. Lancet. 1996;348(9029):729–33. 10.1016/S0140-6736(96)02308-2 . [DOI] [PubMed] [Google Scholar]
  • 15.Pakfetrat A, Falaki F, Delavarian Z, Dalirsani Z, Sanatkhani M, Zabihi Marani M. Oral manifestations of human immunodeficiency virus-infected patients. Iranian journal of otorhinolaryngology. 2015;27(78):43–54. . [PMC free article] [PubMed] [Google Scholar]
  • 16.Groenewegen H, Bierman W, Delli K, Dijkstra P, Nesse W, Vissink A, et al. Severe periodontitis is more common in HIV- infected patients. The Journal of infection. 2019;78(3):171–7. 10.1016/j.jinf.2018.11.008 . [DOI] [PubMed] [Google Scholar]
  • 17.Food Drug Administration Based FAFOFJB, Maryland: US Department of Health Human Services. Rapid HIV Test Kit. 2004.
  • 18.Parish CL, Siegel K, Liguori T, Abel SN, Pollack HA, Pereyra MR, et al. HIV testing in the dental setting: perspectives and practices of experienced dental professionals. AIDS Care. 2017;30(3):347–52. 10.1080/09540121.2017.1367087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chung R, Leung SJ, Abel SN, Hatton MN, Ren Y, Seiver J, et al. HIV screening in the dental setting in New York State. PloS one. 2020;15(4):e0231638. 10.1371/journal.pone.0231638 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Belete W, Deressa T, Feleke A, Menna T, Moshago T, Abdella S, et al. Evaluation of diagnostic performance of non-invasive HIV self-testing kit using oral fluid in Addis Ababa, Ethiopia: A facility-based cross-sectional study. PloS one. 2019;14(1):e0210866. 10.1371/journal.pone.0210866 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Delaney K, Branson B, Uniyal A, Phillips S, Candal D, Owen S, et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;52(2):257–63. 10.1093/cid/ciq068 . [DOI] [PubMed] [Google Scholar]
  • 22.Delaney KP, Branson BM, Uniyal A, Kerndt PR, Keenan PA, Jafa K, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. Aids. 2006;20(12):1655–60. Epub 2006/07/27. 10.1097/01.aids.0000238412.75324.82 . [DOI] [PubMed] [Google Scholar]
  • 23.Zachary D, Mwenge L, Muyoyeta M, Shanaube K, Schaap A, Bond V, et al. Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC infectious diseases. 2012;12(8):183. 10.1186/1471-2334-12-183 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang L, Santella AJ, Huang R, Kou L, You L, Zhang X, et al. Knowledge of HIV and willingness to conduct oral rapid HIV testing among dentists in Xi’an China. PloS one. 2015;10(3):e0119274. 10.1371/journal.pone.0119274 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Park JC, Choi SH, Kim YT, Kim SJ, Kang HJ, Lee JH, et al. Knowledge and attitudes of Korean dentists towards human immunodeficiency virus/acquired immune deficiency syndrome. Journal of periodontal implant science. 2011;41(1):3–9. 10.5051/jpis.2011.41.1.3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ngaihte PC, Santellab A, Wattc R, Rajd S. Envisioning the role of indian dentists in conducting rapid HIV testing for early detection of HIV. International Journal of Development Research. 2015;5(10):5975–7. [Google Scholar]
  • 27.Santella AJ, Schlub TE, Schifter M, Tolani M, Hillman RJ. Australian dentists’ perspectives on rapid HIV testing. Australian dental journal. 2016;61(3):270–6. 10.1111/adj.12371 . [DOI] [PubMed] [Google Scholar]
  • 28.Pollack H, Metsch L, Abel S. Dental examinations as an untapped opportunity to provide HIV testing for high-risk individuals. American journal of public health. 2010;100(1):88–9. 10.2105/AJPH.2008.157230 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Santella A, Conway D, Watt R. The potential role of dentists in HIV screening. JBdj 2016;220(5):229–33. 10.1038/sj.bdj.2016.172 . [DOI] [PubMed] [Google Scholar]
  • 30.P HA, P M, P CL, A S, M S, S R, et al. Dentists’ willingness to provide expanded HIV screening in oral health care settings: results from a nationally representative survey. American journal of public health. 2014;104(5):872–80. 10.2105/AJPH.2013.301700 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Santella A, Nguyen T, Schifter M, Hillman R. Vietnamese dentists’ attitudes and willingness to conduct saliva-based HIV testing. J Dent Res. 2015;94:3907. [Google Scholar]
  • 32.Kassim S, Othman B, AlQahtani S, Kawthar AM, McPherson SM, Greenberg BL. Dentists’ attitudes towards chairside medical conditions screening in a dental setting in Saudi Arabia: an exploratory cross-sectional Study. BMC oral health. 2019;19(1):179. 10.1186/s12903-019-0870-x . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Davide SH, Santella A J, Furnari W, Leuwaisee P, Cortell M, Krishnamachari B. Patients’ Willingness to Participate in Rapid HIV Testing: A pilot study in three New York City dental hygiene clinics. Journal of dental hygiene. 2017;91(6):41–8. . [PubMed] [Google Scholar]
  • 34.Bradley ELP, Vidot DC, Gaul Z, Sutton MY, Pereyra M. Acceptability of oral rapid HIV testing at dental clinics in communities with high HIV prevalence in South Florida. PloS one. 2018;13(4):e0196323. 10.1371/journal.pone.0196323 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ji-feng LIU, Mei-dan LIU, Qian LI, Xiao-mei XIANG, Yong-min X. Epidemiology and analysis of HIV/AIDS in Xi’an between 2005 and 2017 Modern Preventive Medicine. 2019;46(02):353–5+ 84. [Google Scholar]
  • 36.Christopoulos K, Weiser S, Koester K, Myers J, White D, Kaplan B, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC public health. 2012;12(3):1471–2458. 10.1186/1471-2458-12-3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Carey M, Schroder K. Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. AIDS education. 2002;14(2):172–82. 10.1521/aeap.14.2.172.23902 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.90-90-90 An ambitious treatment target to help end the AIDS epidemic, 2014, https://new.pancap.org/pc/pcc/media/pancap_document/90-90-90_Targets.pdf, (accessed Jan 23, 2021). [Internet]. [cited Jan 23, 2021]. https://new.pancap.org/pc/pcc/media/pancap_document/90-90-90_Targets.pdf.
  • 39.van Wijk PT, Meiberg AE, Bruers JJ, Groenewold MH, van Raalten AL, Dam BA, et al. The risk of blood exposure incidents in dental practices in the Netherlands. Community dentistry oral epidemiology. 2012;40(6):567–73. 10.1111/j.1600-0528.2012.00702.x . [DOI] [PubMed] [Google Scholar]
  • 40.Li S, Su S, Li S, Gao L, Cai Y, Fu J, et al. A comparison of effectiveness between oral rapid testing and routine serum-based testing for HIV in an outpatient dental clinic in Yuxi Prefecture, China: a case-control study. BMJ open. 2017;7(6):e014601. 10.1136/bmjopen-2016-014601 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lopez-Quintero C, Rojas P, Dillon FR, Varga LM, De La Rosa M. HIV testing practices among Latina women at risk of getting infected: a five-year follow-up of a community sample in South Florida. AIDS care. 2016;28(2):137–46. 10.1080/09540121.2015.1071769 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Xun H, Kang D, Huang T, Qian Y, Li X, Wilson EC, et al. Factors associated with willingness to accept oral fluid HIV rapid testing among most-at-risk populations in China. PloS one. 2013;8(11):e80594. 10.1371/journal.pone.0080594 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Donnell-Fink LA, Arbelaez C, Collins JE, Novais A, Case A, Pisculli ML, et al. Acceptability of fingerstick versus oral fluid rapid HIV testing: results from the universal screening for HIV infection in the emergency room (USHER Phase II) randomized controlled trial. Journal of acquired immune deficiency syndromes. 2012;61(5):588–92. 10.1097/qai.0b013e31826a6d67 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Baumann KE H V, Kallen MA, Street RL, Giordano TP, Arya M. Whether Patients Want It or Not, Physician Recommendations Will Convince Them to Accept HIV Testing. Journal of the International Association of Providers of AIDS Care. 2018;17:2325957417752258. 10.1177/2325957417752258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Batey DS, Hogan VL, Cantor R, Hamlin CM, Ross-Davis K, Nevin C, et al. Short communication routine HIV testing in the emergency department: assessment of patient perceptions. AIDS research human retroviruses. 2012;28(4):352–6. 10.1089/aid.2011.0074 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Zixin Wang

16 Nov 2020

PONE-D-20-30084

HIV Testing Behaviors and Willingness to Receive Oral Rapid HIV Testing among Dental Patients in Xi’an, China

PLOS ONE

Dear Dr. Wang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 31 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Zixin Wang, PhD.

Academic Editor

PLOS ONE

Additional Editor Comments:

1. Given the very low overall HIV prevalence in China, more justification is needed to support the use of dental clinics settings to increase HIV testing rate. If the aim is to increase HIV testing rate at population level, offering HIV testing at primary healthcare settings would be far more efficient.

2. Opt-out HIV testing is commonly used at clinical settings in some western countries to increase testing rate, which means every patients will receive HIV testing unless they show objection. It is unclear whether opt-in HIV testing (like the author described) would be useful to increase HIV testing, as those who have sexual risk behaviors may choose not to accept the tests. The authors should explain why they look at willingness to use opt-in HIV testing, instead of the more commonly used opt-out HIV testing in clinical settings.

3. The inclusion criteria is a bit confusing. The authors mentioned all dental patients were invited. It is unclear whether the study recruit those under 18 years old?

4. Details of the introduction about ORHT should be included in the manuscript.

5. I read through the manuscript and I was not able to find out how willingness to use ORHT is measured. I do agree with the reviewer that a detailed description of measurements should be included in the manuscript, instead of only referring to some published papers or just mentioning number of items.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You have mentioned that the questionnaire was validated, but not whether it was  pre-tested. Please clarify if it was pre-tested. If this did not occur, please provide the rationale for not doing so.

3. Please correct your reference to "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

4. Please provide further details on sample size and power calculations.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript has a clear and straightforward research question. It aims to assess the HIV testing behaviors and willingness to receive ORHT among dental patients in Xi’an, China.

However, the following issues should be addressed.

1.Measurements should be described in more detailed in the Method section. For instance, were the items rated based on Likert scale? Also, please give examples of the items in the Method section, especially the items about ORHT knowledge and willingness to receive ORHT.

2. What were the reliabilities of the measurements?

3.Can the authors think about presenting a table about the results of each item in percentage. For instance, Q37, what is the percentage of participants chose option 1, 2 and 3 respectively? By having such information, the readers can have a better understanding of the study results.

4.Only 8% of those who were unwilling to receive ORHT chose worrying about being discriminated. In the literature, as fear of being discriminated is one of the major factors for not willing to do HIV test. As 8% in study is relatively low, could the authors give the reasons for this phenomenon?

5.Apart from the variables that were presented in Table 4, any other variables were entered in doing the multiple logistic regression analysis? If so, what are they? Were all the variables that were significant in chi-squared test entered in the multiple logistic regression analysis? Can the authors give a brief description of the rationale for inclusion of variables in the regression analysis?

6.Only 10.6% of the participants were from private dental practice. How this figure would affect the result? Is there any statistics about the number of people attending different types of dental clinics in the study place, Xi’an? If there is a higher proportion of people attending private dental clinics than other types, the results of this study may be distorted. Thus, such kind of information is important.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 25;16(3):e0248585. doi: 10.1371/journal.pone.0248585.r002

Author response to Decision Letter 0


30 Jan 2021

Response to reviewers' comments:

Comment 1: Given the very low overall HIV prevalence in China, more justification is needed to support the use of dental clinics settings to increase HIV testing rate. If the aim is to increase HIV testing rate at population level, offering HIV testing at primary healthcare settings would be far more efficient.

Response to reviewer:

Many thanks for your constructive comment. We have added the relevant information to the Introduction section: “The Chinese government has explored the feasibility of offering HIV testing at primary healthcare settings such as community health centers [11]. However, since China is a low-prevalence country, such a practice is still being explored. More research is needed to evaluate the effectiveness of this setting and other non-traditional settings such as dentistry.” (Page 4 Line 75-79)

[11]. Ong JJ, Peng MH, Wong WW, Lo Y-R, Kidd MR, Roland M, et al. Opportunities and barriers for providing HIV testing through community health centers in mainland China: a nationwide cross-sectional survey. BMC Infectious Diseases. 2019;19(1):1054. doi: 10.1186/s12879-019-4673-0.

Comment 2: Opt-out HIV testing is commonly used at clinical settings in some western countries to increase testing rate, which means every patient will receive HIV testing unless they show objection. It is unclear whether opt-in HIV testing (like the author described) would be useful to increase HIV testing, as those who have sexual risk behaviors may choose not to accept the tests. The authors should explain why they look at willingness to use opt-in HIV testing, instead of the more commonly used opt-out HIV testing in clinical settings.

Response to reviewer:

We thank the reviewers for their comments and suggestions. We have added the relevant information to the Introduction section: “To expand testing venues, opt-out HIV testing has been implemented in medical settings among priority populations since 2008 and settings such as perinatal exams, prenatal exams, pre-operative exams, sexually transmitted disease exams and other types of testing services in China [9]. Almost half (44.7%) of 528,234 persons diagnosed with HIV between 2006 and 2014 in China were diagnosed at hospitals, indicating that most of the HIV testing in China was conducted in health and hospital systems [10]. However, dental patients are nor high-risk groups or sentinel surveillance groups. For both opt-out and opt-in testing, it is necessary to first understand the population’s HIV testing willingness. Otherwise, even if opt-out is carried out, a considerable number of people may refuse to be tested.” (Page 3 Line 66-75)

[9]. Jin Xia, Xiong Ran, Yurong M. HIV/AIDS cases detection in medical institutions from 2008 to 2013 in China. Chinese Journal of Epidemiology. 2015;36(4):323-6.

[10]. Tang H, Mao Y, Tang W, Han J, Xu J, Li J. Late for testing, early for antiretroviral therapy, less likely to die: results from a large HIV cohort study in China, 2006-2014. BMC infectious diseases. 2018;18(1):272. doi: 10.1186/s12879-018-3158-x. PubMed PMID: 29895275.

Comment 3: The inclusion criteria is a bit confusing. The authors mentioned all dental patients were invited. It is unclear whether the study recruit those under 18 years old?

Response to reviewer:

Many thanks for your valuable suggestions. To clarify, we did not invite those under 18 years old to participant our survey. We have revised the Methods section: “Dental patients 18 years and older who visited the sample practices from August to September were invited to participate in the survey”. (Page 6 Line 122-123)

Comment 4: Details of the introduction about ORHT should be included in the manuscript.

Response to reviewer:

Thank you for the suggestions pointed by the reviewer. We have added the relevant information in the Introduction section: “The first oral rapid HIV test (ORHT) was approved by the United States (US) Food and Drug Administration (FDA) in 2004[17]. In the US and other high-income countries, scholars have proposed that ORHT has the potential to improve the diagnosis rate of PLWH [18, 19]. The tests have high sensitivity and specificity; both above 99%[20-22]. It also offers many advantages over blood-based testing and could address several challenges in implementing HIV testing in settings without laboratories [20]. This testing method does not require blood collection, has no risk of occupational exposure and cross-infection, and can prevent the patient from refusing to test because of fear of blood draw [23].” (Page 4 Line 85-92)

[17]. Food Drug Administration Based FAFOFJB, Maryland: US Department of Health Human Services. Rapid HIV Test Kit. 2004.

[18]. Parish CL, Siegel K, Liguori T, Abel SN, Pollack HA, Pereyra MR, et al. HIV testing in the dental setting: perspectives and practices of experienced dental professionals. AIDS Care. 2017;30(3):347-52. doi: 10.1080/09540121.2017.1367087.

[19]. Chung R, Leung SJ, Abel SN, Hatton MN, Ren Y, Seiver J, et al. HIV screening in the dental setting in New York State. PloS one. 2020;15(4):e0231638. doi: 10.1371/journal.pone.0231638. PubMed PMID: 32298336.

[20]. Belete W, Deressa T, Feleke A, Menna T, Moshago T, Abdella S, et al. Evaluation of diagnostic performance of non-invasive HIV self-testing kit using oral fluid in Addis Ababa, Ethiopia: A facility-based cross-sectional study. PloS one. 2019;14(1):e0210866. doi: 10.1371/journal.pone.0210866. PubMed PMID: 30682062.

[21]. Delaney K, Branson B, Uniyal A, Phillips S, Candal D, Owen S, et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52(2):257-63. doi: 10.1093/cid/ciq068. PubMed PMID: 21288853.

[22]. Delaney KP, Branson BM, Uniyal A, Kerndt PR, Keenan PA, Jafa K, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. Aids. 2006;20(12):1655-60. Epub 2006/07/27. doi: 10.1097/01.aids.0000238412.75324.82. PubMed PMID: 16868447.

[23]. Zachary D, Mwenge L, Muyoyeta M, Shanaube K, Schaap A, Bond V, et al. Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC infectious diseases. 2012;12(8):183. doi: 10.1186/1471-2334-12-183. PubMed PMID: 22871032. 

Comment 5: I read through the manuscript and I was not able to find out how willingness to use ORHT is measured. I do agree with the reviewer that a detailed description of measurements should be included in the manuscript, instead of only referring to some published papers or just mentioning number of items.

Response to reviewer:

We agree with that a detailed description of measurements should be included in the manuscript, so we revised the Methods section as follows: The survey instrument was modified from a validated questionnaire from researchers in the U.S. [33]. An expert consensus panel of Chinese dental, sexual health, and epidemiology scholars reviewed a draft questionnaire to conform the validity. The questionnaire was pre-tested among 20 patients in Xi’an, and we modified the questionnaire based on the results, including the order of the questions, some inappropriate options and inaccurate expression of the questions. The final questionnaire consisted of 44 questions, assessing socio-demographic characteristics (eight items), HIV/AIDS knowledge (modified HIV-KQ-18 [37] (fifteen items), HIV testing behaviors (seven items), HIV testing knowledge (six items), ORHT knowledge (three items) and the willingness to receive ORHT (five items). We assessed ORHT knowledge by asking participants what the advantages of ORHT were, the options were high accuracy, quick results, and no need to draw blood. To collect the willingness to receive ORHT, we asked the participants: “If a dentist can carry out Oral Rapid HIV Testing, would you be willing to test it before treating oral diseases?”. The answers were yes, unwilling and unsure. For participants who chose “yes”, we categorized them as willing to use ORHT. (Page 7 Line 139-152)

[33]. Davide SH, Santella A J, Furnari W, Leuwaisee P, Cortell M, Krishnamachari B. Patients' Willingness to Participate in Rapid HIV Testing: A pilot study in three New York City dental hygiene clinics. Journal of dental hygiene. 2017;91(6):41-8. PubMed PMID: 29378805.

[37]. Carey M, Schroder K. Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. AIDS education. 2002;14(2):172-82. doi: 10.1521/aeap.14.2.172.23902. PubMed PMID: 12000234. 

Comment 6: You have mentioned that the questionnaire was validated, but not whether it was pre-tested. Please clarify if it was pre-tested. If this did not occur, please provide the rationale for not doing so.

Response to reviewer:

Thank you for pointing out this issue. We pre-tested the questionnaire before the survey. We revised the Method section as follows: “The questionnaire was pre-tested among 20 patients in Xi’an, and we modified the questionnaire based on the results, including the order of the questions, some inappropriate options and inaccurate expression of the questions.” (Page 7 Line 141-144)

Comment 7: Please correct your reference to "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

Response to reviewer:

Many thanks for pointing out errors. We have revised all “p=0.000” to “p<0.001”.

Comment 8: Please provide further details on sample size and power calculations.

Response to reviewer:

We added the sample size details into the Methods section: “The proportion of participants who were willing to receive ORHT ranged from 24% to 91% [36]. If we take 24% as the expected proportion of our survey, α= 0.01 and the allowable error d=0.15P, according to the formula , which is commonly used to estimate the sample size of cross sectional study, then the approximately sample size would be 934.” (Page 6 Line 123-127)

[36]. Christopoulos K, Weiser S, Koester K, Myers J, White D, Kaplan B, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC public health. 2012;12(3):1471-2458. doi: 10.1186/1471-2458-12-3. PubMed PMID: 22214543. 

Comment 9: Measurements should be described in more detailed in the Method section. For instance, were the items rated based on Likert scale? Also, please give examples of the items in the Method section, especially the items about ORHT knowledge and willingness to receive.

Response to reviewer:

The items of our survey did not base on Likert scale, but we used three categories of responses (described above). Since we focused on the willingness of dental patients, we intended to ask about the specific acceptance level after the willingness, such as cost. We added details as to how we measure ORHT knowledge and willingness to receive ORHT in the method sections (see response above). We feel the revised Methods section addresses this concern.

Comment 10: What were the reliabilities of the measurements?

Response to reviewer:

As you know, reliability refers to the extent to which a scale produces consistent results, if the measurements are repeated a number of times. There are four different approaches: Test-Retest, Internal Consistency Reliability, Split Half Reliability and Inter-Rater Reliability. We considered reliability during the pre-test. However, dental patients are of strong fluidity. It would be virtually impossible and logistically burdensome for us to survey dental patients repeatedly to evaluate the reliability. This is a limitation of the current study.

Comment 11: Can the authors think about presenting a table about the results of each item in percentage. For instance, Q37, what is the percentage of participants chose option 1, 2 and 3 respectively? By having such information, the readers can have a better understanding of the study results.

Response to reviewer:

Thank you very much for pointing out this issue. We added the percentage of each item in the result part: “In details, for the advantages of ORHT, the number of choosing “quick results”, “no need to draw blood” and “high accuracy” are 561(61.7%) ,450(49.5%) and 360(39.6%), respectively. And other questions are showed in Table 3.” (Page 11 Line 202-205).

Table 3 Details about HIV testing knowledge (N=909)

Questions n (answer question correctly) %

AIDS can be tested by venous blood 354 38.90

AIDS can be tested by fingertip blood 200 22.00

AIDS can be tested by oral mucosa exudate 177 19.50

ORHT can get results quickly 561 61.72

ORHT doesn’t need draw blood 450 49.50

ORHT has high accuracy 360 39.60

Comment 12: Only 8% of those who were unwilling to receive ORHT chose worrying about being discriminated. In the literature, as fear of being discriminated is one of the major factors for not willing to do HIV test. As 8% in study is relatively low, could the authors give the reasons for this phenomenon?

Response to reviewer:

Thanks very much for your important question. We have modified the relevant information in the Discussion section: “In our study, 56.6% of 327 participants believed they were sufficiently healthy indicating they were not interested in receiving an ORHT. This is inconsistent with the body of literature that has established the role of discrimination in persons rejecting HIV test offers [45]. One reason for not citing discrimination has a barrier to receiving an ORHT may be because the participants were established patients of the clinic where they were surveyed and satisfied with the quality of dental services they were receiving from their providers.” (Page 18 Line 287-293).

[45]. Batey D, Hogan V, Cantor R, Hamlin C, Ross-Davis K, Nevin C, et al. Short communication routine HIV testing in the emergency department: assessment of patient perceptions. AIDS research human retroviruses. 2012;28(4):352-6. doi: 10.1089/aid.2011.0074. PubMed PMID: 21790474. 

Comment 13: Apart from the variables that were presented in Table 4, any other variables were entered in doing the multiple logistic regression analysis? If so, what are they? Were all the variables that were significant in chi-squared test entered in the multiple logistic regression analysis? Can the authors give a brief description of the rationale for inclusion of variables in the regression analysis?

Response to reviewer:

We added the following sentence to Results section to provide clarification: “All variables in Table 5 were entered in running the multiple logistic regression analysis using the forward: conditional method.” (Page 15 Line 233-234).

Table 5 Variables in multiple logistic regression analysis

Variables value

Willingness to undergo ORHT Y 0=no or unsure;1=yes

Age X1 Actual age of participants

Sex X2 1=male; 2=female

Nationality X3 1=han; 2=others

Education X4 1=high school and low; 2=college and above

Marriage X5 1=unmarried; 2=married

Monthly income X6 1=no more than 5000; 2=less than 5000

Employment status X7 0=unemployed; 1=employed

Type of dental setting visited X9 1=dental hospital; 2=department of dentistry; 3=private dental practice

HIV Knowledge Score X10 Actual score of HIV knowledge (range from 0 to 15)

Previously received an HIV test X11 0=no; 1=yes

Having advanced HIV testing knowledge X12 0=no; 1=yes

Having advanced ORHT knowledge X13 0=no; 1=yes

Comment 14: Only 10.6% of the participants were from private dental practice. How this figure would affect the result? Is there any statistics about the number of people attending different types of dental clinics in the study place, Xi’an? If there is a higher proportion of people attending private dental clinics than other types, the results of this study may be distorted. Thus, such kind of information is important.

Response to reviewer:

Private dental practices in Xi’an are dispersive and have an irregular flow of patients. Additionally, dental hospitals and departments of dentistry in general hospitals are usually at capacity and represent the major source for dental care. This was the main reason that only 10.6% of the participants were from private dental practice. However, fifty-nine (61.46%) of the 96 participants from private dental practice were willing to receive ORHT before dental therapy, similar to the percentage in other types of dental settings. Based on the results of our data, the percentage of participants from private dental practice have little influence on the willingness of the whole dental patients. According to our design, the sequence of promoting ORHT among dental patients is from dental hospitals, departments of dentistry in general hospital to private dental practice. The results of this research are essential for the further promotion of ORHT among dental patients. In addition, we added the following to address this concern in the Discussion section: “We recruited less participants from private dental practices because some private dental practice refused to participate because of fear of affecting the patient's medical experience, which may lead to some section bias.” (Page 20 Line 316-319).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Zixin Wang

2 Mar 2021

HIV Testing Behaviors and Willingness to Receive Oral Rapid HIV Testing among Dental Patients in Xi’an, China

PONE-D-20-30084R1

Dear Dr. Wang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Zixin Wang, PhD.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Zixin Wang

16 Mar 2021

PONE-D-20-30084R1

HIV Testing Behaviors and Willingness to Receive Oral Rapid HIV Testing among Dental Patients in Xi’an, China

Dear Dr. Wang:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Zixin Wang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (SAV)

    S1 Questionnaire

    (DOCX)

    S2 Questionnaire

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES